[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Placebo-controlled, Multi-center, Randomized, Phase 2b Study to Evaluate the Efficacy
and Safety of ORMD-0801 in Type 2 Diabetes Mellitus Patients with Inadequate Glycemic Control on Oral

What is the purpose of the study?

The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin. ORMD-0801 will be referred to as the “study drug” throughout this ICF. An experimental drug is also called an “investigational drug”.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Patient Age Group:


Principal Investigator:

Ruth S Weinstock, MD, PhD

Who can I contact for more information?

Name: Suzan M Bzdick, RN
Phone: 315-464-9006
Email: bzdicks@upstate.edu

Return to Previous Page || Search Again